GHG.L Regulatory News (GHG)

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

GEORGIA HEALTHCARE GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

T. Rowe Price Associates, Inc.

4. Full name of shareholder(s)  (if different from 3.):iv

Bank of New York Mellon (FL)

Bank of New York Mellon Bank, N.A.

JP Morgan Chase

State Street Bank & Trust Co

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

08 April 2016

6. Date on which issuer notified:

14 April 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BYSS4K11

6,347,933

6,347,933

6,860,375

6,860,375

5.20%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,860,375

5.20%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of Georgia Healthcare Group Plc, including the T. Rowe Price International Discovery Fund, Inc., which owns 4,932,042 shares. Such shares are registered in the following name(s):

Bank of New York Mellon (FL) - 97,928

Bank of New York Mellon Bank, N.A. - 136,797

JP Morgan Chase - 6,483,208

State Street Bank & Trust Co. - 142,442

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Gary Greb, Vice President

T. Rowe Price Associates, Inc.

15. Contact telephone number:

001 410 345 2527